External validation of the RISC, RISC-Malawi, and PERCH clinical prediction rules to identify risk of death in children hospitalized with pneumonia.
Journal
Journal of global health
ISSN: 2047-2986
Titre abrégé: J Glob Health
Pays: Scotland
ID NLM: 101578780
Informations de publication
Date de publication:
2021
2021
Historique:
entrez:
5
11
2021
pubmed:
6
11
2021
medline:
9
11
2021
Statut:
epublish
Résumé
Existing scores to identify children at risk of hospitalized pneumonia-related mortality lack broad external validation. Our objective was to externally validate three such risk scores. We applied the Respiratory Index of Severity in Children (RISC) for HIV-negative children, the RISC-Malawi, and the Pneumonia Etiology Research for Child Health (PERCH) scores to hospitalized children in the Pneumonia REsearch Partnerships to Assess WHO REcommendations (PREPARE) data set. The PREPARE data set includes pooled data from 41 studies on pediatric pneumonia from across the world. We calculated test characteristics and the area under the curve (AUC) for each of these clinical prediction rules. The RISC score for HIV-negative children was applied to 3574 children 0-24 months and demonstrated poor discriminatory ability (AUC = 0.66, 95% confidence interval (CI) = 0.58-0.73) in the identification of children at risk of hospitalized pneumonia-related mortality. The RISC-Malawi score had fair discriminatory value (AUC = 0.75, 95% CI = 0.74-0.77) among 17 864 children 2-59 months. The PERCH score was applied to 732 children 1-59 months and also demonstrated poor discriminatory value (AUC = 0.55, 95% CI = 0.37-0.73). In a large external application of the RISC, RISC-Malawi, and PERCH scores, a substantial number of children were misclassified for their risk of hospitalized pneumonia-related mortality. Although pneumonia risk scores have performed well among the cohorts in which they were derived, their performance diminished when externally applied. A generalizable risk assessment tool with higher sensitivity and specificity to identify children at risk of hospitalized pneumonia-related mortality may be needed. Such a generalizable risk assessment tool would need context-specific validation prior to implementation in that setting.
Sections du résumé
BACKGROUND
BACKGROUND
Existing scores to identify children at risk of hospitalized pneumonia-related mortality lack broad external validation. Our objective was to externally validate three such risk scores.
METHODS
METHODS
We applied the Respiratory Index of Severity in Children (RISC) for HIV-negative children, the RISC-Malawi, and the Pneumonia Etiology Research for Child Health (PERCH) scores to hospitalized children in the Pneumonia REsearch Partnerships to Assess WHO REcommendations (PREPARE) data set. The PREPARE data set includes pooled data from 41 studies on pediatric pneumonia from across the world. We calculated test characteristics and the area under the curve (AUC) for each of these clinical prediction rules.
RESULTS
RESULTS
The RISC score for HIV-negative children was applied to 3574 children 0-24 months and demonstrated poor discriminatory ability (AUC = 0.66, 95% confidence interval (CI) = 0.58-0.73) in the identification of children at risk of hospitalized pneumonia-related mortality. The RISC-Malawi score had fair discriminatory value (AUC = 0.75, 95% CI = 0.74-0.77) among 17 864 children 2-59 months. The PERCH score was applied to 732 children 1-59 months and also demonstrated poor discriminatory value (AUC = 0.55, 95% CI = 0.37-0.73).
CONCLUSIONS
CONCLUSIONS
In a large external application of the RISC, RISC-Malawi, and PERCH scores, a substantial number of children were misclassified for their risk of hospitalized pneumonia-related mortality. Although pneumonia risk scores have performed well among the cohorts in which they were derived, their performance diminished when externally applied. A generalizable risk assessment tool with higher sensitivity and specificity to identify children at risk of hospitalized pneumonia-related mortality may be needed. Such a generalizable risk assessment tool would need context-specific validation prior to implementation in that setting.
Identifiants
pubmed: 34737862
doi: 10.7189/jogh.11.04062
pii: jogh-11-04062
pmc: PMC8542381
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
04062Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Informations de copyright
Copyright © 2021 by the Journal of Global Health. All rights reserved.
Déclaration de conflit d'intérêts
Competing interests: The authors have completed the ICMJE Declaration of Interest Form (available upon request from the corresponding author), and declare no conflicts of interest. YBN is staff member of the World Health Organization.
Références
Malar J. 2007 Dec 19;6:168
pubmed: 18093319
PLoS One. 2012;7(1):e27793
pubmed: 22238570
Clin Infect Dis. 2017 Aug 15;65(4):604-612
pubmed: 28605562
Arch Dis Child. 2012 Apr;97(4):336-42
pubmed: 22267369
Pediatrics. 2012 Apr;129(4):701-8
pubmed: 22392179
Pediatr Infect Dis J. 2018 Aug;37(8):743-748
pubmed: 29278608
Lancet. 2015 Jan 31;385(9966):430-40
pubmed: 25280870
Pediatr Infect Dis J. 2000 May;19(5):424-32
pubmed: 10819338
Lancet Glob Health. 2018 Jan;6(1):e74-e83
pubmed: 29241618
Pediatr Pulmonol. 2016 Jun;51(6):588-95
pubmed: 26613245
Lancet. 2015 Dec 5;386(10010):2275-86
pubmed: 26361942
PLoS One. 2014 Mar 25;9(3):e92968
pubmed: 24667695
J Pediatr. 2017 Mar;182:375-377.e2
pubmed: 27939107
PLoS One. 2019 Jun 20;14(6):e0214583
pubmed: 31220085
Public Health Nutr. 2016 Oct;19(14):2513-20
pubmed: 27049813
Am J Clin Nutr. 2013 Jun;97(6):1387-94
pubmed: 23636236
Lancet. 2005 Jan 1-7;365(9453):43-52
pubmed: 15643700
Lancet Infect Dis. 2020 Jan;20(1):60-79
pubmed: 31678026
High Alt Med Biol. 2020 Jun;21(2):114-125
pubmed: 32239983
Lancet. 2019 Aug 31;394(10200):757-779
pubmed: 31257127
Clin Infect Dis. 2017 Jun 15;64(suppl_3):S378-S386
pubmed: 28575375
BMJ Glob Health. 2020 Aug;5(8):
pubmed: 32792409
Ann Am Thorac Soc. 2016 Jul;13(7):1123-8
pubmed: 27159648
Lancet. 2013 Apr 20;381(9875):1380-1390
pubmed: 23369797
Pediatrics. 2017 Sep;140(3):
pubmed: 28835381
Lancet Glob Health. 2019 Jun;7(6):e721-e734
pubmed: 31097276
N Engl J Med. 2020 Jul 2;383(1):13-23
pubmed: 32609979
Lancet. 2005 Mar 26-Apr 1;365(9465):1139-46
pubmed: 15794968
PLoS One. 2016 Dec 28;11(12):e0168126
pubmed: 28030608
Lancet HIV. 2019 Dec;6(12):e831-e859
pubmed: 31439534
J Infect. 2016 Nov;73(5):393-401
pubmed: 27519619
Clin Infect Dis. 2020 Mar 3;70(6):1050-1057
pubmed: 31111870
PLoS One. 2019 Jun 13;14(6):e0217570
pubmed: 31194750
Curr Infect Dis Rep. 2019 Mar 5;21(3):10
pubmed: 30834468
BMJ Open. 2020 Oct 19;10(10):e035045
pubmed: 33077558
N Engl J Med. 2003 Oct 2;349(14):1341-8
pubmed: 14523142
Pediatr Infect Dis J. 2013 Nov;32(11):1175-9
pubmed: 23694836
BMJ. 2008 Jan 12;336(7635):80-4
pubmed: 18182412
J Glob Health. 2015 Dec;5(2):050418
pubmed: 26528392
N Engl J Med. 2020 Dec 17;383(25):2477-2478
pubmed: 33326721
Clin Infect Dis. 2005 Apr 15;40(8):1079-86
pubmed: 15791504